Drugs giant AstraZeneca has admitted that the formulation patent protecting its Seroquel XR product was deemed invalid by the High Court in the UK.
The patent was challenged by Accord Healthcare, Intas Pharmaceuticals, Hexal AG and Sandoz, Teva UK, and Teva Pharmaceutical Industries.
MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
AstraZeneca said it is "disappointed" with the court's decision and added that the company remains committed to defending its intellectual property protecting Seroquel XR.
Shares were down 0.26% to 2,844.00p.
NR
-
Park Plaza: the perfect calm in AmsterdamEnjoy a peaceful stay in the vibrant and largest city of the Netherlands - and why the Park Plaza, Vondelpark, could be the perfect stop for anyone looking for a bit of calm while still able to enjoy all that Amsterdam has to offer.
-
4 ways HENRYs can use their pension to keep more of their six-figure incomesA £100,000 salary isn’t what it used to be, after tax and other penalties. But by putting some of your current earnings into a pension you can end up holding onto more of your income in future. Here’s what you need to know if you’re a ‘HENRY’ – High Earners but Not Rich Yet.
